V030-0696 Screening compound: 3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-N-(4-methoxyphenyl)propanamide

V030-0696 Screening compound: 3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-N-(4-methoxyphenyl)propanamide
V030-0696 Screening compound: 3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-N-(4-methoxyphenyl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-0696
3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-N-(4-methoxyphenyl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-0696

Molecular Formula

C32H27N3O2S (C32 H27 N3 O2 S)

Compound Name

3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-N-(4-methoxyphenyl)propanamide

IUPAC name

3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[12-a]pyridin-3-yl]-N-(4-methoxyphenyl)propanamide

SMILES

Cc(cc1)ccc1-c1c(CCC(Nc(cc2)ccc2OC)=O)n(cc(cc2)-c3cc(cccc4)c4s3)c2n1

InChI

InChI=1S/C32H27N3O2S/c1-21-7-9-22(10-8-21)32-27(16-18-31(36)33-25-12-14-26(37-2)15-13-25)35-20-24(11-17-30(35)34-32)29-19-23-5-3-4-6-28(23)38-29/h3-15,17,19-20H,16,18H2,1-2H3,(H,33,36)

InChI Key

KYIOGNIBPBRUDH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20494697

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

517.65

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

7.479

Distribution Coefficient, logD

7.463

Water Solubility, LogSw

-6.31

Polar Surface Area

39.395

Acid Dissociation Constant (pKa)

11.92

Base Dissociation Constant (pKb)

5.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

V030-0696 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V030-0696 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-0696?
Check Price and Availability of V030-0696, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-0696 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-0696
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-0696
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-0696 available by request